Page last updated: 2024-09-05

iclaprim and Drug Abuse, Intravenous

iclaprim has been researched along with Drug Abuse, Intravenous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balser, B; Corey, GR; Huang, DB; Noviello, S; Scaramucci, A	1

Trials

1 trial(s) available for iclaprim and Drug Abuse, Intravenous

Article	Year
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies. Clinical therapeutics, 2019, Volume: 41, Issue:6 Topics: Administration, Intravenous; Anti-Bacterial Agents; Double-Blind Method; Humans; Pyrimidines; Skin Diseases, Bacterial; Substance Abuse, Intravenous; Treatment Outcome; Vancomycin	2019

Article

Year

A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies.

Clinical therapeutics, 2019, Volume: 41, Issue:6

Topics: Administration, Intravenous; Anti-Bacterial Agents; Double-Blind Method; Humans; Pyrimidines; Skin Diseases, Bacterial; Substance Abuse, Intravenous; Treatment Outcome; Vancomycin

2019